MSB 3.42% $1.21 mesoblast limited

Cell Therapy News/Articles, page-4149

  1. 12 Posts.
    lightbulb Created with Sketch. 171
    meso new patent filed - Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells
    http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2020902312
    Last edited by TechFan20: 10/07/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.